Edition:
United States

Pharming Group NV (PHGUF.PK)

PHGUF.PK on OTC Markets Group - US Other OTC and Grey Market

0.37USD
--
Change (% chg)

-- (--)
Prev Close
$0.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
418,087
52-wk High
$0.40
52-wk Low
$0.17

PHGUF.PK

Chart for PHGUF.PK

About

Pharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company’s products... (more)
No analyst recommendations are available for PHGUF.PK.

Overall

No Ratios Available.

Financials

  PHGUF.PK Industry Sector
P/E (TTM): -- 142.93 17.37
EPS (TTM): -- -- --
ROI: -- 2.34 -5.89
ROE: -- 0.22 -5.30

BRIEF-Pharming withdraws items related to amendment of articles of association from AGM agenda

* PHARMING ANNOUNCES WITHDRAWAL OF AGENDA ITEMS RELATED TO AMENDMENT OF THE ARTICLES OF ASSOCIATION FROM AGM AGENDA SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Gdynia Newsroom:)

May 17 2017

BRIEF-Pharming Group Q1 operating result swings to EUR 3.9 mln profit

* Q1 NET PRODUCT SALES INCREASED BY 794% TO €15.2 MILLION (2016: €1.7 MILLION),

May 17 2017

BRIEF-Pharming announces refinancing of its existing debt by single $100 million debt facility on improved commercial terms

* PHARMING ANNOUNCES REFINANCING OF ITS EXISTING DEBT BY A SINGLE US$100 MILLION DEBT FACILITY ON IMPROVED COMMERCIAL TERMS

May 16 2017

BRIEF-Pharming Group FY net loss widens to 17.5 million euros

* FY revenue from product sales 13.7 million euros ($14.43 million) versus 8.6 million euros year ago

Mar 09 2017

BRIEF-Pharming Group announces additional conversions of its amortizing bonds

* Total number of shares issued in conversions is 7,558,479 ordinary shares

Feb 03 2017

BRIEF-Pharming Group announces issue of new stock

* Announces issue of new stock as a result of conversion of amortizing bonds

Jan 26 2017

BRIEF-EC amends marketing authorisation for Pharming Group's Ruconest to include self-administration

* European Commission amends marketing authorisation for Ruconest to include self-administration

Jan 16 2017

More From Around the Web

Earnings vs. Estimates